FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,<i>In Vitro,</i>Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells
Stéphane Hunot(Centre National de la Recherche Scientifique), Étienne C. Hirsch(Sorbonne Université)
Cited by 359
Related Papers
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
Gait Disorders in Parkinsonian Monkeys with Pedunculopontine Nucleus Lesions: A Tale of Two Systems
|Journal of Neuroscience|2013|86